TOKYO/LONDON -- Countries around the world are shoveling huge sums at drug companies to aid development, clinical trials and mass production of COVID-19 vaccines, overshadowing coordinated global efforts.
Capitals prioritize national drives over international cooperation

Countries around the world are investing big in crash programs to develop a vaccine for the coronavirus. © Reuters
TOKYO/LONDON -- Countries around the world are shoveling huge sums at drug companies to aid development, clinical trials and mass production of COVID-19 vaccines, overshadowing coordinated global efforts.